echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 100 billion level market shuffle! Key point of drug selection in centralized purchase

    100 billion level market shuffle! Key point of drug selection in centralized purchase

    • Last Update: 2019-11-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends] since this year, in response to the "opinions on strengthening the performance appraisal of three-level public hospitals" issued earlier by the state, all regions have carried out active and effective exploration in the performance appraisal of public hospitals A few days ago, Shanghai Health and Health Commission released its localization implementation plan "notice on printing and Distributing" (hereinafter referred to as "notice") jointly formulated by Shanghai Medical Insurance Bureau, Shanghai Administration of traditional Chinese medicine, Shanghai development and Reform Commission and other departments Focus on the proportion of drugs used in centralized purchase In the notice, a total of 60 assessment indicators are specified, including not only reasonable drug use indicators such as prescription comments, antibacterial drug use, proportion / utilization rate of outpatient / inpatient basic drug prescription, basic drug procurement varieties, proportion of winning drugs in national organization volume procurement, but also deviation rate of composite index cost of each disease in hospital and implementation of health care phase Indicators are put forward in terms of relevant system, score of bad practice in hospitals and construction of professional style It is worth noting that, with the development of volume procurement in China, the proportion of selected drugs has become the focus of public hospitals In the evaluation index of Shanghai three-level public hospitals, the calculation method of the proportion of the winning drugs in the centralized purchase of drugs organized by the state is: the amount of winning drugs / the amount of the same kind of drugs × 100% As the index guidance of the proportion of winning drugs in the centralized purchase of drugs organized by the state is gradually improved, the amount of winning drugs will be correspondingly increased Industry insiders said that the purpose of the pilot work of volume procurement is to solve the long-term outstanding problems in the centralized procurement process, such as unreasonable mechanism, large amount of unnecessary costs, and the resulting unreasonable use of drugs, high drug prices, so as to purify the industrial environment and reduce the prices In the future, the regulatory level will be more and more strict, the rational drug use policy will be implemented, the performance appraisal will be used to refine the indicator management, and the auxiliary drug use will be strictly controlled in an all-round way Varieties with large clinical dosage, high purchase amount, top ranking and obvious dosage increase will be strictly controlled In fact, since January this year, after the state issued the opinions on strengthening the performance appraisal work of three-level public hospitals (hereinafter referred to as the opinions), it marks the official opening of the new era of comprehensive performance appraisal of three-level hospitals, and the implementation plans of performance appraisal of public hospitals have been issued by all regions Earlier, the general office of the people's Government of Jiangxi Province issued the implementation opinions on strengthening the performance appraisal of three-level public hospitals It was proposed that Jiangxi would establish the performance appraisal index system of three-level public hospitals of non traditional Chinese medicine and traditional Chinese medicine respectively based on the four aspects of medical quality, operation efficiency, sustainable development and satisfaction evaluation The results of the assessment will become an important basis for the financial investment and the adjustment of medical insurance policy of the third level public hospitals By the end of 2019, the performance appraisal of three-level public hospitals will be launched in an all-round way, and a relatively complete performance appraisal system of three-level public hospitals will be basically established in 2020 In September, the Beijing Municipal People's government also officially released the implementation plan for performance appraisal of three-level public hospitals Its evaluation index system consists of four dimensions and 60 indexes, including medical quality, operation efficiency, sustainable development and innovation satisfaction evaluation It is also mentioned that in the dynamic adjustment process, priority will be given to the national essential drug catalogue In addition, the general office of Hubei provincial government issued the implementation plan for performance appraisal of three-level public hospitals in Hubei Province, which said that 58 detailed indicators will be used for performance appraisal in five dimensions of medical quality, operation efficiency, sustainable development, satisfaction evaluation and social benefit By 2020, a relatively complete three-level public hospital performance appraisal system will be established In 2021, the performance appraisal scope of public hospitals will be gradually expanded To strengthen the performance evaluation of public hospitals is an important responsibility of the government, an important means to establish an effective incentive and constraint mechanism, guide the public hospitals to correct the direction and behavior of running hospitals, and improve the level of hospital professional management Industry insiders believe that in the future, with the deepening of the performance appraisal of tertiary hospitals, the hospital market and regional market of 100 billion level will face huge pressure of reshuffle.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.